Loading viewer...
investor_presentation
Format: PDF investor_presentation
Second Quarter 2022 Results August 15, 2022 NASDAQ: IONM
Second Quarter 2022 Results
Cautionary Note regarding Forward -Looking Statements
This presentation may contain “forward -looking statements” within the meaning of applicable securities laws. Forward -looking sta tements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans,"
"should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or si milar expressions. Forward -looking statements include, but are not limited to, statements regarding forecasts of managed
cases and remote neurology managed cases, the effect of cost reductions and projected savings, financial projections, includi ng the company being Adjusted EBITDA and cash flow positive in the second half of 2022, and other similar
statements. These statements are based upon the current expectations and beliefs of management and are subject to certain ris ks and uncertainties that could cause actual results to differ materially from those described in the forward -
looking statements. These risks include risks regarding our patient volume or cases not growing as expected, or decreasing, w hich could impact revenue and profitability; unfavorable economic conditions could have an adverse effect on our
business; risks related to increased leverage resulting from incurring additional debt; the policies of health insurance carr iers may affect the amount of revenue we receive; our ability to successfully market and sell our products and services; we
may be subject to competition and technological risk which may impact the price and amount of services we can sell and the na ture of services we can provide; regulatory changes that are unfavorable in the states where our operations are
conducted or concentrated; our ability to comply and the cost of compliance with extensive existing regulation and any change s or amendments thereto; changes within the medical industry and third -party reimbursement policies and our
estimates of associated timing and costs with the same; our ability to adequately forecast expansion and the Company’s manage men t of anticipated growth; and risks and uncertainties discussed in our most recent annual and quarterly reports
filed with the United States Securities and Exchange Commission, including our annual report on Form 10 -K filed on March 14, 202 2, and with the Canadian securities regulators and available on the Company’s profiles on EDGAR at
www.sec.gov and SEDAR at www.sedar.com , which risks and uncertainties are incorporated herein by reference. Readers are cautioned not to place undue reliance on fo rwa rd-looking statements. Except as required by law, Assure does not
intend, and undertakes no obligation, to update any forward -looking statements to reflect, in particular, new information or fut ure events.
Non -GAAP Financial Measures
Preview truncated — download the full document for the complete content.
investor_presentation
19 Pages
Assure Holdings Investor Presentation — March 2022
investor_presentationinvestor_presentation
19 Pages
investor_presentation
22 Pages
Waters Corporation
CMG Investor Presentation 2024 - Simulation Technology
investor_presentationinvestor_presentation
23 Pages
CMG (Computer Modelling Group Ltd.)
Regeneron Pharmaceuticals Investor Presentation — June 2021
investor_presentationinvestor_presentation
22 Pages
Regeneron Pharmaceuticals, Inc.